How many institutional investors hold AYTU?

1 tracked institutional investor disclosed a position in AYTU (AYTU BIOPHARMA INC) in their most recent 13F filing.

Who is the largest institutional holder of AYTU?

Ken Griffin, Citadel Advisors, holds the largest disclosed position in AYTU, valued at $106,240.

Where does this AYTU ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

AYTU — AYTU BIOPHARMA INC

Name: AYTU BIOPHARMA INC (AYTU) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying AYTU?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Net accumulation · 1 buying vs 0 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Why? — Evidence & Confidence ▾

Of 1 tracked investors who changed their AYTU position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime).

Supporting evidence

+1 tracked investor added or increased positions last quarter (Ken Griffin)
+1 tracked investors reported holding AYTU at their latest filing
+Macro Health is 55/100 in a Squeeze regime — historically acceptable for this sectorsource

Contradicting evidence — always shown

−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/20/2026.

About AYTU BIOPHARMA INC (AYTU)

AYTU BIOPHARMA INC (AYTU) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $106,240. Across recent filings, tracked investors recorded 2 new positions, 2 increased, 0 reduced, and 3 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in AYTU

/100

Mixed Activity

Added / Increased4

Reduced0

Exited3

BearishBullish

Crowded Trade Score™

How many top investors track AYTU

/100

Undiscovered

1investor

Only 1 tracked investor report this position.

UndiscoveredCrowded

151015+

AYTU Ownership Composition

How AYTU BIOPHARMA INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Multi-Strategy / Quant

100% of tracked value

Institutions

tracked investors

Total Reported

$106.2K

combined 13F value

Multi-Strategy / Quant100.0%

Multi-Strategy / Quant(1)

100.0%

Tracked investors currently reporting AYTU

1 tracked investor has since exited this position — listed separately below.

Investor	Firm	Shares	Market value	% of portfolio	As of
Ken Griffin	Citadel Advisors	49.4K	$106.2K	0.00%	Jun 30, 2026

Ken GriffinJun 30, 2026
Citadel Advisors
Shares
49.4K
Value
$106.2K
% Portfolio
0.00%

Previously held AYTU

These investors reported AYTU in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

Investor	Firm	Last reported shares	Value then	Last held
Izzy Englander	Millennium Management	10.4K	$17.3K	Dec 31, 2024

Recent activity

Investor	Action	Δ %	Current value	Filing date
Izzy Englander	New	—	$17.3K	Feb 14, 2025
Izzy Englander	Sold	-100.00%	$0	May 15, 2025
Ken Griffin	Sold	-100.00%	$0	Nov 14, 2024
Ken Griffin	Increased	175.66%	$36.6K	May 15, 2025
Ken Griffin	Sold	-100.00%	$0	Aug 14, 2025
Ken Griffin	Increased	34.13%	$106.2K	Aug 14, 2026
Ken Griffin	New	—	$63.5K	Aug 14, 2024

Izzy Englander
New
$17.3KFeb 14, 2025
Izzy Englander
Sold
$0(-100.00%)May 15, 2025
Ken Griffin
Sold
$0(-100.00%)Nov 14, 2024
Ken Griffin
Increased
$36.6K(175.66%)May 15, 2025
Ken Griffin
Sold
$0(-100.00%)Aug 14, 2025
Ken Griffin
Increased
$106.2K(34.13%)Aug 14, 2026
Ken Griffin
New
$63.5KAug 14, 2024

Frequently asked questions

How many institutional investors hold AYTU?: 1 tracked institutional investor disclosed a position in AYTU (AYTU BIOPHARMA INC) in their most recent 13F filing.
Who is the largest institutional holder of AYTU?: Ken Griffin, Citadel Advisors, holds the largest disclosed position in AYTU, valued at $106,240.
Did institutional ownership of AYTU increase or decrease?: Across recent 13F filings, tracked investors recorded 2 new positions, 2 increased, 0 reduced, and 3 fully exited AYTU.
Where does this AYTU ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.